![Peter Guenter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Guenter
Direktor/Vorstandsmitglied bei
IPSEN
Vermögen: 14 300 $ am 31.05.2026
Profil
Peter Guenter is currently Director at Ipsen SA since 2026, Director at Vicore Pharma Holding AB since 2026, and Director at the European Federation of Pharmaceutical Industries & Assns.
Formerly, Mr. Guenter was Chief Executive Officer & Director at Almirall SA from 2017 to 2020, Member-Management Board & CEO-Healthcare at Merck KGaA from 2021 to 2025, Chief Executive Officer at Merck Healthcare KGaA, Chairman-Supervisory Board at Sanofi-Aventis Deutschland GmbH, Independent Non-Executive Director at Lakefront Biotherapeutics from 2019 to 2025, EVP, General Manager-Diabetes & Cardiovascular at Sanofi from 2013 to 2017, and Executive Vice President at Smithkline Beecham.
Education includes graduation from Ghent University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 501 ( 0 % ) | 14 300 $ | 31.05.2026 |
Aktive Positionen von Peter Guenter
| Unternehmen | Position | Beginn |
|---|---|---|
| IPSEN | Direktor/Vorstandsmitglied | 28.01.2026 |
| VICORE PHARMA HOLDING AB | Direktor/Vorstandsmitglied | 07.05.2026 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter Guenter
| Unternehmen | Position | Ende |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direktor/Vorstandsmitglied | 28.07.2025 |
| MERCK KGAA | Corporate Officer/Principal | 01.06.2025 |
| ALMIRALL, S.A. | Vorstandsvorsitzender | 31.12.2020 |
| SANOFI | Corporate Officer/Principal | 01.08.2017 |
Merck Healthcare KGaA
 Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Vorstandsvorsitzender | - |
Ausbildung von Peter Guenter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Smithkline Beecham | |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
